PXMD News
Archived Headlines
- Micro-cap neurodevelopment biotech PaxMedica relaunches $8 million IPO 08/08/22
- Biotech PaxMedica updates blank filing with new proposed deal size ahead of $15 million IPO 06/10/22
- Neurodevelopment biotech PaxMedica revives $29 million IPO with new blank filing 01/04/22
- Micro-cap neurodevelopment biotech PaxMedica ups share offering, adds warrants ahead of $15 million IPO 09/29/20
- US IPO Week Ahead: The September IPO calendar stays Good(Rx) and busy in an 8 IPO week 09/18/20
See more
Renaissance Capital's August IPO Market Update
While August is typically a slow month for capital markets, monthly issuance reached double digits for the first time this year as 12 small IPOs raised a combined $196 million. The largest deal raised just $36 million, and the median deal size remained low at...read more
US IPO Weekly Recap: Summer IPO market marches on with more small deals
Six small deals priced this past week, though only three met the criteria for our 2022 IPO stats. Pipeline activity picked up with three new IPO filings, including a biotech that...read more
Neurodevelopment biotech PaxMedica prices IPO at $5.25, within the range
PaxMedica, a Phase 2 biotech developing therapies for neurodevelopmental disorders, raised $8 million by offering 1.5 million shares at $5.25, slightly below the midpoint of the $4.50 to $6.50 range. PaxMedica originally filed for an IPO in July 2020, most...read more
US IPO Week Ahead: More micro-cap IPOs
After an active week by 2022 standards, as many as four more micro-cap IPOs are scheduled to price in the third week of August. If the current market rally continues, we may see an increase in filing activity following Labor Day. ...read more